Search

everythinglearnresearchcommunity

for

Search:↓

Overexpressing SSAT enzyme reduces prostate tumor growth in mice.

LY191704 is a compound that effectively blocks a specific enzyme involved in hormone conversion and could help treat enlarged prostate and hair loss.

FCE 28260 is a stronger and longer-lasting inhibitor of 5α-reductase than finasteride, which may make it a better treatment for certain medical conditions.

Dutasteride works better than finasteride for preventing and treating prostate cancer.

D-004 may be a natural alternative to finasteride for treating enlarged prostate and male baldness.

Scientists made new substances that can block an enzyme linked to prostate issues and hair loss, with potential for creating a new treatment.

Finasteride reduces prostate cancer risk by 30% without affecting Gleason scores.

Finasteride for hair loss may cause painless bleeding in urine and semen.

Finasteride may reduce bleeding after TURP, but more research needed.

Antiandrogens affect androgen-dependent body functions and are used for various medical conditions, with some risks like fetus feminization, but new forms like 17α-propylmesterolone show promise for acne without systemic effects.

Long-term testosterone therapy can cause hormone suppression, affect prostate and heart health, and alter physical characteristics, but does not increase prostate cancer risk and needs more research for full risk assessment.

The length of the CAG repeat in the androgen receptor gene affects the risk and progression of prostate cancer, BPH, infertility, and undermasculinized genitalia.

Low androgen levels might delay prostate cancer but could lead to more aggressive, therapy-resistant cancers.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

Medications for BPH can have significant side effects, so understanding these risks is important for treatment decisions.

Ganoderma lucidum may help treat prostate cancer by blocking male hormones and slowing cancer cell growth.

Hormone therapy for prostate cancer can increase heart risks, especially in men with heart conditions.

TMPRSS2 helps viruses enter cells and protects the prostate from inflammation-related cancer.

DHT is a strong androgen that may pose less risk to the prostate compared to testosterone.

Liquorice may reduce testosterone and affect male reproductive organs, potentially helping treat conditions like prostate cancer.

Smaller substituents at C-17 enhance the inhibitory activity of progesterone derivatives on 5alpha-reductase.

No definitive link between finasteride and male breast cancer, but further research is needed.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

Drinking a lot of alcohol increases the risk of prostate cancer and can worsen the condition.

Kigelia africana fruit extract can prevent and reverse prostate enlargement in rats.

Finasteride may cause breast enlargement, low testosterone a risk factor.

The developed model can predict effective 5-alpha-reductase enzyme inhibitors.

Plant-based compounds might be effective, low-side-effect treatments for prostate cancer by blocking a specific enzyme.

Higher testosterone and DHT levels are linked to hair loss in men, but not to prostate cancer risk.

Plant-based treatments may help reduce BPH symptoms, but more research is needed.